PTGX
HealthcareProtagonist Therapeutics, Inc.
Prev Close
$95.42
Open
$96.91
High
$98.30
Low
$91.04
Volume
653.9K
Market Cap
$6.15B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Protagonist Therapeutics, Inc. (PTGX) has been exclusively selling, with 0 insider purchases totaling $0.00 and 9 insider sales totaling $18.78M. The most recent insider transaction was by Williams Lewis T (director), who sold $1.48M worth of shares on Feb 18, 2026. Protagonist Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $6.15B.
PTGX Insider Trading Activity
PTGX Insider Buying Activity
The following table shows recent insider purchases of Protagonist Therapeutics, Inc. (PTGX) stock reported via SEC Form 4 filings.
No insider buying activity found for PTGX in the last 12 months.
PTGX Insider Selling Activity
The following table shows recent insider sales of Protagonist Therapeutics, Inc. (PTGX) stock reported via SEC Form 4 filings.